Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
08/2008
08/28/2008WO2008103613A2 Hydroxylamine compounds and methods of their use
08/28/2008WO2008103277A2 Nitrogen-containing heterocyclyl ketones and their use as c-met inhibitors
08/28/2008WO2008101905A1 Aryl carboxylic acid cyclohexyl amide derivatives
08/28/2008WO2008101867A1 Purine derivatives as immunomodulators
08/28/2008WO2008080120A3 3-amino chromane derivatives
08/28/2008WO2008059513A3 Compounds suitable as modulators of hdl
08/28/2008WO2007087488A9 Indole sulfonamide modulators of progesterone receptors
08/28/2008US20080207921 purified polylactic acid or glycolic acid-lactic acid copolymer; insert for drugs
08/28/2008US20080207909 Preparation of 11C Methyl Iodide
08/28/2008US20080207728 Bicyclic acyltryptophanols
08/28/2008US20080207725 Skin disorders; antiinflamamtory agenst; antiallergens
08/28/2008US20080207720 Novel Imidazolecarboxamide Derivatives as Fructose-1,6-Bisphosphatase Inhibitors, and Pharmaceutical Compositions Comprising Same
08/28/2008US20080207696 Phenacyl 2-Hydroxy-3-Diaminoalkanes
08/28/2008US20080207636 Using a benzmide compound; antidiabetic agents; obesity
08/28/2008US20080207613 Selective Kinase Inhibitors
08/28/2008US20080207612 Analgesics; pain management
08/28/2008US20080207608 Stroke; antiinflammatory agents; sepsis; allograft; transplant rejection; antitumor agents; liver disorders; brain hemorrage; neurodegenerative diseases ; vision defects
08/28/2008CA2679066A1 Hydroxylamine compounds and methods of their use
08/28/2008CA2678514A1 Chemical linkers with single amino acids and conjugates thereof
08/28/2008CA2677565A1 Aryl carboxylic acid cyclohexyl amide derivatives
08/28/2008CA2676173A1 Nitrogen-containing heterocyclyl ketones and their use as c-met inhibitors
08/27/2008EP1962354A1 Organic electroluminescence element material and organic electroluminescence element using same
08/27/2008EP1961750A1 Vla-4 inhibitory drug
08/27/2008EP1961748A2 2-hydroxy-3-heteroarylindole derivatives as GSK3 inhibitors
08/27/2008EP1961416A1 Medical use of inhibitors of glutaminyl and glutamate cyclases
08/27/2008EP1960386A2 Substituted cycloalkylpyrrolones as allosteric modulators of glucokinase
08/27/2008EP1960370A1 Pyridiazinone derivatives for tumour treatment
08/27/2008EP1960367A2 Substituted pyrazole compounds useful as soluble epoxide hydrolase inhibitors
08/27/2008EP1960365A2 Azonafide derivatives, methods for their production and pharmaceutical compositions therefrom
08/27/2008EP1960363A2 Quinolone based compounds exhibiting prolyl hydroxylase inhibitory activity, and compositions, and uses thereof
08/27/2008EP1960347A2 17-beta-hydroxysteroid dehydrogenase type 3 (17beta-hsd3) inhibitors
08/27/2008EP1751144B1 Constrained himbacine analogs as thrombin receptor antagonists
08/27/2008EP1708996B1 Fused heteroyral derivatives for use as p38 kinase inhibitors
08/27/2008EP1474146B1 Phenylpyrimidine amines as ige inhibitors
08/27/2008EP1408036B1 Process for producing benzofuran derivative
08/27/2008EP1368325B1 New asymmetric process for the preparation of diarylmethylpiperazines derivatives and novel asymmetric diarylmetylamines as intermediates
08/27/2008EP0649429B1 Heteroatomic oligonucleoside linkages
08/27/2008CN101253166A Sulfonamide compound
08/27/2008CN101253147A Organic compounds
08/27/2008CN101253131A Method for isolating 5-substituted tetrazoles
08/27/2008CN101250163A Process for producing epoxytriazole compound and intermediate therefor
08/27/2008CN100413859C Sulfonated amino acid derivatives and metalloproteinase inhibitors containing same
08/27/2008CN100413849C Benzimidazole derivatives
08/27/2008CN100413539C The use of 5ht4 receptor antagonists in the prophylaxis or treatment of certain cardiovascular conditions
08/26/2008US7417145 Process for total synthesis of ecteinascidins and intermediates therefor
08/26/2008US7417057 insecticides; safe for crops; Fused partially unsaturated carbocyclic or heterocyclic ring substituted with a 5-or 6-membered heterocyclic ring such as imidazole, thiazole, oxazole, 1,3,4-oxadiazole
08/26/2008US7417056 5-substituted quinoline and isoquinoline derivatives, a process for their production and their use as anti-inflammatory agents
08/26/2008US7417043 3-substituted 4-(phenyl-N-alkyl)-piperazine derivatives; central nervous system disorders; dualistic dopaminergic action profile with antagonist-like effects on brain neurochemistry and mild agonist-like effects on normal behavior, induce inhibition of behavior in hyperactivity; oral bioavailability
08/26/2008CA2532743C Intermediates for preparing dialkyl-halogenophenyl-substituted ketoenols
08/26/2008CA2432129C Pyrazole compounds useful as protein kinase inhibitors
08/26/2008CA2329230C A process for the manufacture of sulfonylaminocarbonyl triazolinones in the presence of xylene as solvent
08/26/2008CA2274825C Substituted nitrogen containing heterocycles as inhibitors of p38 protein kinase
08/26/2008CA2171550C Nucleosides with anti-hepatitis b virus activity
08/21/2008WO2008100651A2 Preparation of darifenacin and its salts
08/21/2008WO2008100459A1 Derivatives and analogs of chroman as functionally selective alpha2c adrenoreceptor agonists
08/21/2008WO2008099804A1 Therapeutic agent for diabetic cataract
08/21/2008WO2008099794A1 Fused ring compounds as partial agonists of ppar-gamma
08/21/2008WO2008099165A1 Piperidine derivatives and their use for treatment of ccr8 mediated diseases
08/21/2008WO2008099145A1 Pyrazole derivatives as 11-beta-hsd1 inhibitors
08/21/2008WO2008099076A2 Substituted n-(4-cyano-1h-pyrazol-3-yl)methylamine derivatives, preparation thereof and therapeutic use thereof
08/21/2008WO2008098978A2 Benzofuran compounds useful in the treatment of conditions mediated by the action of pge2 at the ep1 receptor
08/21/2008WO2008098859A1 Hcv polymerase inhibitors
08/21/2008WO2008068614A3 Stereoselective synthesis of 1-[6-ethyl-1,2-dihydroxy-propyl)-pyridin-3-yl]-3-[2-(4-methyl-piperazin-1-yl)-benzyl]-pyrrolidin-2-one
08/21/2008WO2008034736A3 Oxindole derivatives as anticancer agents
08/21/2008WO2008031550A3 Nicotinic acid derivatives as modulators of metabotropic glutanate receptors
08/21/2008WO2007139955A3 Triazole compounds that modulate hsp90 activity
08/21/2008US20080200524 Treating pain, inflammation and traumatic injury; using 2-pyridinyl-phenyl-4-amido-p-sulfono or sulfonamidobenzene derivatives
08/21/2008US20080200509 Utilizing such as 4-(2,6-dichloro-benzoylamino)-1H-pyrazole-3-carboxylic acid piperidin-4-ylamide against cancer growth
08/21/2008US20080200469 Phthalazinone derivatives
08/21/2008US20080200446 1,4-Diphenyl-3-substituted azetidin-2-ones; can be metabolized in vivo to form a sterol and/or stanol absorption inhibitor and a sterol biosynthesis inhibitor for treatment of atherosclerosis, hypercholesterolemia, or sitosterolemia
08/21/2008CA2679849A1 Functionally selective alpha2c adrenoreceptor agonists
08/21/2008CA2678069A1 Derivatives and analogs of chroman as functionally selective alpha2c adrenoreceptor agonists
08/21/2008CA2678036A1 Functionally selective alpha2c adrenoreceptor agonists
08/21/2008CA2677736A1 Fused ring compounds as partial agonists of ppar-gamma
08/21/2008CA2677649A1 Bioavailable formulations of heterocyclic compounds
08/21/2008CA2676715A1 Piperazine derivatives for treatment of ad and related conditions
08/21/2008CA2676154A1 Pyrazole derivatives as 11-beta-hsd1 inhibitors
08/21/2008CA2672955A1 New 2, 4-dianilinopyrimidines, preparation thereof as drugs, pharmaceutical compositions and use thereof essentially as ikk inhibitors
08/20/2008EP1958948A1 Pyridazine compound and use thereof
08/20/2008EP1958945A1 Compound having hydrocoumarin skeleton, liquid crystal composition and liquid crystal display element
08/20/2008EP1958939A2 Pyrazole-amine compounds for the treatment of neurodegenerative disorders
08/20/2008EP1958633A2 Process and intermediate compounds useful in the preparation of statins, particularly rosuvastatin
08/20/2008EP1957511A2 Process for the large scale production of stavudine
08/20/2008EP1957499A1 4-anilino-substituted quinazoline derivatives as tyrosine kinase inhibitors
08/20/2008EP1957483A1 Novel vinylogous acids derivatives
08/20/2008EP1957479A2 1,5-substituted indol-2-yl amide derivatives
08/20/2008EP1957478A2 New compounds
08/20/2008EP1957466A1 4-aminopyrimidine-5-thione-derivatives for the treatment of cancer
08/20/2008EP1957460A1 Bicyclic compounds with kinase inhibitory activity
08/20/2008EP1957058A1 Compounds for the treatment of inflammatory disorders and microbial diseases
08/20/2008EP1685102A4 Melanocortin receptor agonists
08/20/2008EP1670790B1 Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
08/20/2008EP1670770B1 Benzimidazole derivatives, compositions containing them, preparation therof and uses thereof
08/20/2008EP1404653B1 Triamide-substituted indoles, benzofuranes and benzothiophenes as inhibitors of microsomal triglyceride transfer protein (mtp) and/or apolipoprotein b (apo b) secretion
08/20/2008CN101248062A C-fms kinase inhibitors
08/20/2008CN101248059A Substituted amide derivatives as protein kinase inhibitors
08/20/2008CN101248044A Novel indole compounds
08/20/2008CN101247853A Substituted indole compounds having NOS inhibitory activity
08/20/2008CN101245097A Inhibitors of serine proteases, particular hcv NS3-NS4 protease
08/20/2008CN101245046A Process for synthesizing 3-indole-1-propylene compounds and uses thereof
1 ... 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 ... 694